Glaukos (GKOS) Research & Development (2014 - 2026)
Glaukos' (GKOS) quarterly Research & Development came in at $44.1 million in Q1 2026, up 36.45% year-on-year from $32.4 million in Q1 2025, and up 1.13% on a QoQ basis from $43.7 million in Q4 2025.
Glaukos (GKOS) Research & Development (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Research & Development data on file, last reported at $44.1 million in Q1 2026.
- On a quarterly basis, Research & Development rose 36.45% year-over-year to $44.1 million in Q1 2026; TTM through Mar 2026 was $162.4 million, a 17.64% increase from a year earlier, with the FY2025 full-year figure at $150.6 million, up 10.4% from the prior year.
- Research & Development for Q1 2026 stood at $44.1 million, up from $43.7 million in the prior quarter.
- Over the last five years, Research & Development for GKOS reached as high as $44.1 million in Q1 2026 and fell as low as $26.9 million in Q1 2022.
- Historically, Research & Development has averaged $34.9 million across 5 years, with a median of $34.7 million in 2024.
- Across the five-year window, Research & Development declined 12.64% in 2024 and jumped 36.45% in 2026, its largest moves.
- Year by year, Research & Development stood at $35.8 million in 2022, then rose by 3.49% to $37.1 million in 2023, then fell by 1.44% to $36.5 million in 2024, then climbed by 19.5% to $43.7 million in 2025, then climbed by 1.13% to $44.1 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $44.1 million in Q1 2026, $43.7 million in Q4 2025, and $38.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 44.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.15 Mn |
| Dec 31, 2025 | 43.65 Mn |
| Sep 30, 2025 | 38.07 Mn |
| Jun 30, 2025 | 36.54 Mn |
| Mar 31, 2025 | 32.35 Mn |
| Dec 31, 2024 | 36.53 Mn |
| Sep 30, 2024 | 34.75 Mn |
| Jun 30, 2024 | 34.43 Mn |
| Mar 31, 2024 | 30.73 Mn |
| Dec 31, 2023 | 37.06 Mn |
| Sep 30, 2023 | 33.30 Mn |
| Jun 30, 2023 | 33.23 Mn |
| Mar 31, 2023 | 35.17 Mn |
| Dec 31, 2022 | 35.81 Mn |
| Sep 30, 2022 | 28.87 Mn |
| Jun 30, 2022 | 31.71 Mn |
| Mar 31, 2022 | 26.88 Mn |
| Dec 31, 2021 | 26.68 Mn |
| Sep 30, 2021 | 28.85 Mn |
| Jun 30, 2021 | 24.26 Mn |